Lisa Drake’s Protocol (Glutamine Alternatives + Food/Activity Journal)

May 30 (edited) • 🔬Protocols & Case Studies

Lisa shared her personal metabolic protocol — not as medical advice, but to showcase alternatives to DON for glutamine inhibition, plus a detailed food/activity journal and drug sensitivity testing (Onconomics Plus by RGCC). She based her decisions on lab results to guide which drugs and nutraceuticals to include or omit.

✅ Scientific & Philosophical Insights

Focus on Press-Pulse strategy: combining glucose/glutamine inhibition, fasting, HBOT, and nutraceuticals.
Belief that cancer is a mitochondrial metabolic disease, not a genetic one.
Lisa emphasized practical implementation in the real world, not theoretical models.
Her journal tracked macros, GKI, energy, and treatment timing to optimize synergy.

✅ Practical Wisdom from Community

Egg Scrambled suggested R-ALA instead of ALA, and Pterostilbene instead of Resveratrol for better bioavailability.
Discussion on 2DG as a glucose blocker before HBOT.
Stephen Mecke recommended sulforaphane for prostate and other cancers — highlighted enzyme myrosinase importance and shared links.
Mi Mo commented on CTC trends and her own carnivore experience.
Lisa’s non-negotiables include keto macros, fasting windows, sleep schedule, and daily rebounding/earthing.

✅ Resources & References Shared

Lisa’s Onconomics Plus RGCC Report (CTC: 2.2 cells/ml).
Supplements purchased from Chemist Warehouse, iHerb, NutriNZ, Bob Harrison Dispensary, Poten-C NZ, MCSFormulas.
Research links on:

• Ketogenic diet

• Glutamine metabolism

• ReDO protocol

• Vitamin C, Quercetin, Curcumin, HBOT

• Earthing, Contrast Therapy, Apoptosis markers

✅ Key Takeaways

Lisa’s protocol includes over 30 nutraceuticals, 10+ repurposed drugs, HBOT, fasting, and infrared therapy.
Glutamine inhibitors used: Fenbendazole, Sodium Phenylbutyrate, Dipyridamole, Loratadine, Ursolic Acid, Hesperidin, EGCG — as DON alternatives.
IV Vitamin C, Capecitabine, DCA, Metformin, Cimetidine, and Propranolol all included based on test sensitivity.
Daily lifestyle factors (sleep, fasting, movement, rebounder, tracking GKI) treated as core therapies, not extras.
This protocol is a strong case study in patient-led, test-informed, multi-modal metabolic therapy.

Original Post

2 comments